Ace Cardiopathy Solutions Private Limited - Company Profile

It is a healthcare private limited company based in New Delhi, Delhi, India, established in 2009.
2009 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Ace Cardiopathy Solutions Private Limited

Ace Cardiopathy Solutions Private Limited, a active private limited company, was established on 01 December 2009 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U51909DL2009PTC196486. Registered under ROC Roc Delhi Ii. it is unlisted. It has an authorized capital of ₹3.50 M and a paid-up capital of ₹2.98 M.

It upholds a compliant status. Employing 67 professional, Its leadership includes Umesh Munjal (Director), Gaurav Manocha (Director), Som Suresh Mirpagar (Additional Director). Past directors included Bhawana Munjal, Tilak Raj Dua, Prem Sethi. It holds ₹52.62 Cr open charges and ₹15.70 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 551, 5Th Floor Krishna Apra Business Square Netaji Subhash Place, New Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U51909DL2009PTC196486

  • Registration Number

    196486

  • Incorporation Date

    01 December 2009

  • Authorized Capital

    ₹3.50 M

  • Paid-Up Capital

    ₹2.98 M

  • ROC Code

    Roc Delhi Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.50 M
  • Paid Up Capital ₹ 2.98 M
  • Company Age 16 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 52.62 Cr
  • Satisfied Charges ₹ 15.70 Cr
  • Revenue Growth **** 4.55%
  • Profit Growth **** -29.85%
  • Ebitda **** -7.40%
  • Net Worth 51.65%
  • Total Assets **** 26.77%
Company report

Ace Cardiopathy Solutions Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Ace Cardiopathy Solutions Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ace Cardiopathy Solutions Private Limited?
Current Directors
Name Designation Appointment Date Status
Umesh Munjal Director 01 Dec 2009 Current
Gaurav Manocha Director 10 Jul 2012 Current
Som Suresh Mirpagar Additional Director 10 Feb 2026 Current
Keyur Deepak Gandhi Additional Director 10 Feb 2026 Current
Sandip Kumar Dey Additional Director 10 Feb 2026 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 06 Mar 2014 Past
Pramod Abcsdd Director 06 Mar 2014 Past
Pramod Abcsdd Additional Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ace Cardiopathy Solutions.

Ace Cardiopathy Solutions Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 4.55% increase. The company also saw a substantial fall in profitability, with a 29.85% decrease in profit. The company's net worth Soared by an impressive increase of 51.65%.

Ace Cardiopathy Solutions revenue growth over time
Ace Cardiopathy Solutions profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.55%
*******
*******
*******
*******
Revenue from Operations
*******
 4.29%
*******
*******
*******
*******
Total Assets
*******
 26.77%
*******
*******
*******
*******
Profit or Loss
*******
 -29.85%
*******
*******
*******
*******
Net Worth
*******
 51.65%
*******
*******
*******
*******
EBITDA
*******
 -7.40%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ace Cardiopathy Solutions?

In 2024, Ace Cardiopathy Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹526,184,327.00

Satisfied Charges

₹156,960,000.00

Charges Breakdown by Lending Institutions
  • Others : 23.89 Cr
  • Axis Bank Limited : 18.52 Cr
  • Standard Chartered Bank : 7.95 Cr
  • Hdfc Bank Limited : 2.26 Cr
Latest Charge Details
Date Lender Amount Status
22 Sep 2025 Others ₹6.05 Cr Open
28 Jul 2025 Axis Bank Limited ₹17.49 Cr Open
03 Jun 2025 Hdfc Bank Limited ₹1.67 M Open
09 Apr 2025 Hdfc Bank Limited ₹1.52 M Open
28 Mar 2024 Others ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Ace Cardiopathy Solutions?

Ace Cardiopathy Solutions has a workforce of 67 employees as of Oct 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ace Cardiopathy Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ace Cardiopathy Solutions's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ace Cardiopathy Solutions
Recent Activity within the Organization
  • Director Appointment

    Som Suresh Mirpagar was appointed as a Additional Director was appointed as a Additional Director on 10 Feb 2026 & has been associated with this company since 3 months 29 days . was recorded as a recent event.

  • Director Appointment

    Keyur Deepak Gandhi was appointed as a Additional Director was appointed as a Additional Director on 10 Feb 2026 & has been associated with this company since 3 months 29 days . was recorded as a recent event.

  • Director Appointment

    The activity Sandip Kumar Dey was appointed as a Additional Director was appointed as a Additional Director on 10 Feb 2026 & has been associated with this company since 3 months 29 days . was completed.

  • Annual General Meeting

    Ace Cardiopathy Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge with Others amounted to Rs. 60.50 M with Charge ID 101174113 was registered on 22 Sep 2025. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 175.92 M registered on 16 Feb 2020 with Charge ID 100347640 was modified on 22 Sep 2025. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Ace Cardiopathy Solutions Private Limited?

The CIN of Ace Cardiopathy Solutions Private Limited is U51909DL2009PTC196486.

Where is Ace Cardiopathy Solutions Private Limited headquartered?

Ace Cardiopathy Solutions Private Limited is headquartered at 551, 5Th Floor Krishna Apra Business Square Netaji Subhash Place, New Delhi, Delhi, 110034.

When was Ace Cardiopathy Solutions Private Limited incorporated?

Ace Cardiopathy Solutions Private Limited was incorporated on 01 December 2009.

Who are the current directors of Ace Cardiopathy Solutions Private Limited?

The current directors of Ace Cardiopathy Solutions Private Limited are

What is the primary industry of Ace Cardiopathy Solutions Private Limited?

The primary industry of Ace Cardiopathy Solutions Private Limited is Trade.

Is Ace Cardiopathy Solutions Private Limited a listed company?

Ace Cardiopathy Solutions Private Limited is unlisted.

What is the capital structure of Ace Cardiopathy Solutions Private Limited?

The authorized capital of Ace Cardiopathy Solutions Private Limited is ₹3.50 M, and the paid-up capital is ₹2.98 M.

What is the compliance status of Ace Cardiopathy Solutions Private Limited?

The compliance status of Ace Cardiopathy Solutions Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available